<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30165321</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">2210-2612</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>51</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>International journal of surgery case reports</Title>                <ISOAbbreviation>Int J Surg Case Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>A case of undifferentiated pleomorphic sarcoma of the breast with lung and bone metastases.</ArticleTitle>            <Pagination>                <MedlinePgn>143-146</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S2210-2612(18)30316-X</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijscr.2018.07.049</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Undifferentiated pleomorphic sarcoma (UPS) constitutes less than of all sarcomas in adults and rarely involves the breast. We herein present a patient with UPS of the breast with lung and bone metastases. This case was treated by eribulin as first chemotherapy, and performed mastectomy for local control.</AbstractText>                <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 55-year-old female presented a tumor measuring over 5 cm with pain in the right breast. Pathology of the incisional biopsy specimen led to a diagnosis of UPS. Computed tomography revealed a right tumor, right pubic tumor with osteolysis, and multiple lung metastases. She was started on eribulin; however, the tumor grew in size, indicating progressive disease, and the patient underwent simple mastectomy for local control. Pathological evaluation of the excised tumor was consistent with UPS. The patient elected palliative treatment and died due to respiratory failure caused by multiple lung metastases that exacerbated four months after surgery.</AbstractText>                <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Soft tissue sarcomas with distant metastases are treated with chemotherapy; however, there are currently no effective chemotherapeutic agents for UPS of the breast. Given the potential efficacy of eribulin in soft tissue tumors and the easy management of associated side effects, the patient was treated with eribulin, which however was insufficient for disease control.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The prognosis of UPS with distant metastasis remains poor. Treatment approaches including chemotherapy and surgery should be considered based on the patient's general condition, prognosis, and expectations on quality of life.</AbstractText>                <CopyrightInformation>Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Yamazaki</LastName>                    <ForeName>Haruhiko</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan. Electronic address: h.yamazaki0413@kcch.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shimizu</LastName>                    <ForeName>Satoru</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Yokohama Tsurugamine Hospital, Yokohama, Japan. Electronic address: shimizustr0110@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yoshida</LastName>                    <ForeName>Tatsuya</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan. Electronic address: tyoshida0803@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Suganuma</LastName>                    <ForeName>Nobuyasu</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan. Electronic address: nsuganuma@kcch.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yamanaka</LastName>                    <ForeName>Takashi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan. Electronic address: mtintksh@msn.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yamashita</LastName>                    <ForeName>Toshinari</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan. Electronic address: tyamashita@kcch.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rino</LastName>                    <ForeName>Yasushi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan. Electronic address: rino@med.yokohama-cu.ac.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Masuda</LastName>                    <ForeName>Munetaka</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan. Electronic address: mmasuda@yokohama-cu.ac.jp.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Int J Surg Case Rep</MedlineTA>            <NlmUniqueID>101529872</NlmUniqueID>            <ISSNLinking>2210-2612</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2016 Apr 16;387(10028):1629-37</RefSource>                <PMID Version="1">26874885</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Mar 12;377(9769):914-23</RefSource>                <PMID Version="1">21376385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Rev Anticancer Ther. 2014 Jun;14(6):705-10</RefSource>                <PMID Version="1">24611696</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathology. 2014 Feb;46(2):95-104</RefSource>                <PMID Version="1">24378391</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2004 Jul 19;91(2):237-41</RefSource>                <PMID Version="1">15187996</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2017 Oct;18(10):1397-1410</RefSource>                <PMID Version="1">28882536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Surg Case Rep. 2016;24:203-5</RefSource>                <PMID Version="1">27281361</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2014 Apr;15(4):415-23</RefSource>                <PMID Version="1">24618336</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Surg. 2016 Oct;34:180-186</RefSource>                <PMID Version="1">27613565</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1995 Jan 1;75(1 Suppl):257-69</RefSource>                <PMID Version="1">8001000</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast</Keyword>            <Keyword MajorTopicYN="N">Chemotherapy</Keyword>            <Keyword MajorTopicYN="N">Undifferentiated pleomorphic sarcoma</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30165321</ArticleId>            <ArticleId IdType="pii">S2210-2612(18)30316-X</ArticleId>            <ArticleId IdType="doi">10.1016/j.ijscr.2018.07.049</ArticleId>            <ArticleId IdType="pmc">PMC6117951</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>